An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors
NCT ID: NCT05868746
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2023-06-16
2024-06-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB
NCT04129346
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
NCT05277935
Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors
NCT03072966
Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue
NCT03657628
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
NCT01837563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Own an Android or iPhone smartphone and willing to use the smartphone to complete app-based surveys during the assessment period.
* Willing to wear the ActiGraph monitor during the assessment period.
* Willing to wear the study issued Fitbit Versa 3 smartwatch during the assessment period.
* Access to internet to complete REDCap survey assessments.
Exclusion Criteria
* Evidence of major contraindications for exercise per the 2020 Physical Activity Readiness-Questionnaire (PAR-Q)+.
* Currently pregnant.
* History of severe mental illness or currently taking mood stabilizing medications (antipsychotics, anticonvulsants, or lithium).
* Evidence of moderate-severe depressive symptoms (indicated by a score ≥ 10 on Patient Health Questionnaire-8). -Evidence of moderate-severe cognitive impairment (indicated by a score \< 3 on a 6- item cognitive screener).
* Evidence of clinically significant substance use as indicated by a score of ≥ 2 on the CAGE-AID screener.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Cancer Society, Inc.
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Courtney J. Stevens
Assistant Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Courtney J Stevens, PhD
Role: PRINCIPAL_INVESTIGATOR
Dartmouth-Hitchcock Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dartmouth-Hitchcock Clinic
Lebanon, New Hampshire, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRG-21-136-36-IRG
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
STUDY02000934_1B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.